JPMorgan raised the firm’s price target on Cushman & Wakefield to $17 from $14 and keeps a Neutral rating on the shares. The firm remains constructive on the commercial real estate brokers heading into 2025. While the “easy money” has been made, the companies are on the front end of a rebound in commercial real estate sales and leasing activity that could last several years and result in a “beat-and-raise earnings cycle,” the analyst tells investors in a research note. JPMorgan sees “outsized” earnings growth through 2027 when compared with the broader equity market.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CWK:
- Cushman & Wakefield initiated with a Sell at Goldman Sachs
- Boeing union to end strike, Palantir reports Q3 beat: Morning Buzz
- Cushman & Wakefield Reports Strong Leasing Growth and Debt Repayment
- Cushman & Wakefield reports Q3 adjusted EPS 23c, consensus 21c
- CWK Upcoming Earnings Report: What to Expect?
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue